Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Di Carlo

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|January 3, 2022
Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall SurvivalCarlo Sorrentino, Luigi D'Antonio, Cristiano Fieni, et al.
Journal of Clinical Medicine|October 23, 2019
Intraocular Biopsy and ImmunoMolecular Pathology for "Unmasking" Intraocular Inflammatory DiseasesRodolfo Mastropasqua, Emma Di Carlo, Carlo Sorrentino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2014
IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentationFabio Morandi, Emma Di Carlo, Soldano Ferrone, et al.
Cancer Research|March 1, 2018
Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and MetastasizationCarlo Sorrentino, Stefania L Ciummo, Giuseppe Cipollone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2013
Interleukin-30 expression in prostate cancer and its draining lymph nodes correlates with advanced grade and stageSerena Di Meo, Irma Airoldi, Carlo Sorrentino, et al.
Molecular Biomedicine|June 24, 2026
Prostatic fibroblast reprogramming by Interleukin-30 activates prostate cancer metastasis programsStefania Livia Ciummo, Carlo Sorrentino, Simona Marchetti, et al.
Cancer Research|April 19, 2006
Methylation of the IL-12Rbeta2 gene as novel tumor escape mechanism for pediatric B-acute lymphoblastic leukemia cellsIrma Airoldi, Claudia Cocco, Emma Di Carlo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumorCristiana Guiducci, Emma Di Carlo, Mariella Parenza, et al.
Journal for Immunotherapy of Cancer|March 17, 2023
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survivalLuigi D'Antonio, Cristiano Fieni, Stefania Livia Ciummo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2009
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillanceEmma Di Carlo, Tommaso D'Antuono, Paolo Pompa, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|January 3, 2022
Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall SurvivalCarlo Sorrentino, Luigi D'Antonio, Cristiano Fieni, et al.
Journal of Clinical Medicine|October 23, 2019
Intraocular Biopsy and ImmunoMolecular Pathology for "Unmasking" Intraocular Inflammatory DiseasesRodolfo Mastropasqua, Emma Di Carlo, Carlo Sorrentino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2014
IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentationFabio Morandi, Emma Di Carlo, Soldano Ferrone, et al.
Cancer Research|March 1, 2018
Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and MetastasizationCarlo Sorrentino, Stefania L Ciummo, Giuseppe Cipollone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2013
Interleukin-30 expression in prostate cancer and its draining lymph nodes correlates with advanced grade and stageSerena Di Meo, Irma Airoldi, Carlo Sorrentino, et al.
Molecular Biomedicine|June 24, 2026
Prostatic fibroblast reprogramming by Interleukin-30 activates prostate cancer metastasis programsStefania Livia Ciummo, Carlo Sorrentino, Simona Marchetti, et al.
Cancer Research|April 19, 2006
Methylation of the IL-12Rbeta2 gene as novel tumor escape mechanism for pediatric B-acute lymphoblastic leukemia cellsIrma Airoldi, Claudia Cocco, Emma Di Carlo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumorCristiana Guiducci, Emma Di Carlo, Mariella Parenza, et al.
Journal for Immunotherapy of Cancer|March 17, 2023
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survivalLuigi D'Antonio, Cristiano Fieni, Stefania Livia Ciummo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2009
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillanceEmma Di Carlo, Tommaso D'Antuono, Paolo Pompa, et al.
Pageof 10